U.S. Biotech Stock News

QUALCOMM (QCOM) has put capital returns in the spotlight, with its board approving a new US$20b share repurchase program along with a quarterly dividend increase to US$0.92 per share, or US$3.68 annually. See our latest analysis for QUALCOMM. The new capital return program lands after a tough stretch for the stock, with a 90 day share price return of 25.10% decline and a year to date share price return of 24.58% decline, even though the 3 year total shareholder return of 14.54% and 5 year...

FinVolution Group (NYSE:FINV) has drawn attention after reporting resilient full-year 2025 results, highlighting stronger overseas contributions, entry into Australia via the Fundo acquisition, and a shareholder return program with increased dividends and substantial buybacks. See our latest analysis for FinVolution Group. At a latest share price of $5.88, FinVolution’s 7 day share price return of 10.11% and 30 day share price return of 6.14% suggest building momentum following the 2025...

In March 2026, Accenture and Databricks announced that Albertsons Companies is working with them to deploy an AI-powered pricing intelligence platform across its grocery network. This collaboration aims to use advanced data and AI tools to refine pricing decisions, which could help Albertsons address its margin challenges and enhance its customer value proposition. We’ll now examine how Albertsons’ AI-powered pricing initiative with Accenture and Databricks could influence the company’s...

If you are wondering whether Steven Madden at around US$32.61 is offering good value today, you are not alone. Many investors are asking the same question. The share price has pulled back recently, with a 4.2% decline over the last 7 days and a 16.8% decline over the last 30 days, even though the 1 year return stands at 31.1%. Recent headlines have focused on Steven Madden as part of broader conversations about consumer durables stocks and changing expectations around discretionary spending,...

Earlier in March 2026, Cheniere Energy agreed to issue US$1.00 billion of 5.200% Senior Notes due 2036 and US$750.00 million of 6.000% Senior Notes due 2056 in a private offering, while also securing expanded long-term LNG orders from Thailand running through 2041. The combination of fresh long-dated funding and a larger 15-year LNG commitment from Thailand highlights Cheniere’s emphasis on locking in contracted volumes and financial flexibility amid global supply disruptions. We’ll now...

Event-driven focus on Intuitive Machines Intuitive Machines (LUNR) is back in focus after reporting fourth quarter results, highlighting its shift toward commercial operations anchored by a US$4.8b NASA contract and the US$800m Lanterra Space Systems acquisition. See our latest analysis for Intuitive Machines. The recent quarterly update and contract wins come after a volatile year for the stock, with a 66.91% 3 month share price return and a 149.45% 1 year total shareholder return. This...

AtaiBeckley (NasdaqGM: ATAI) published peer reviewed Phase 2a clinical trial results for BPL-003 in treatment resistant depression, reporting rapid and durable antidepressant effects with a favorable safety profile. The company confirmed its Phase 3 trial timeline for BPL-003, targeting a Q2 2026 start following a completed FDA End of Phase 2 meeting. AtaiBeckley completed the acquisition of Beckley Psytech Limited and re domiciled its corporate headquarters to Delaware, reshaping its...

CVS Health Foundation commits US$2.24 million to a new Health Zone initiative in Charlotte's Historic West End, targeting mobile clinics, healthy food access, and social services. The Health Zone investment is designed to support community partners that aim to improve health outcomes and reduce preventable hospitalizations. A CVS Health (NYSE:CVS) public policy leader joins the board of Bioliberty following the health technology firm's latest funding round. The Bioliberty board appointment...

Starbucks, NasdaqGS:SBUX, reported a data breach affecting its Partner Central platform, exposing employee personal information. The incident directly involves Starbucks partners, whose data is used for internal HR and workforce management. The breach comes while Starbucks is engaged in ongoing labor negotiations that include calls for stronger workplace protections. Starbucks operates a global coffee retail and consumer packaged goods business, with its brand closely tied to customer...

Recent performance snapshot OneMain Holdings (OMF) has drawn attention after recent trading, with the share price closing at $49.97 and delivering a 1 day return of 0.89% and a past week return of 7.12%. Over the past month the stock shows a 12.19% decline, widening to a 26.91% decline over the past 3 months. Year to date performance reflects a 27.65% decline against a 1 year total return of 8.09%. See our latest analysis for OneMain Holdings. OMF’s recent 1 month and 3 month share price...

Flipkart, majority owned by Walmart, has completed its relocation to India, a key step toward a potential stock market listing in Mumbai before 2027. The redomicile clears an important regulatory hurdle and more closely aligns Flipkart with India’s e-commerce market. This move is financially relevant for Walmart given Flipkart’s role within its international portfolio. For Walmart (NasdaqGS:WMT), Flipkart’s shift to India comes at a time when the shares trade at $121.98. The stock has risen...

NVIDIA’s GTC 2026 announcements put Synopsys (SNPS) at the center of a push to apply agentic AI and GPU acceleration across electronic design, simulation, and verification, highlighting new frameworks, customer workloads, and cross-industry engineering use cases. See our latest analysis for Synopsys. Despite the flurry of GTC 2026 announcements and new product launches, Synopsys shares have eased back. The 90 day share price return shows a decline of 6.43% and the year to date share price...

For readers wondering whether Chipotle Mexican Grill is still priced for perfection or starting to look more interesting on valuation grounds, this article walks through the numbers so you can assess the value case for yourself. The stock last closed at US$32.64, with returns of a 3.6% decline over 7 days, a 10.1% decline over 30 days, a 12.9% decline year to date, and a 33.4% decline over the past year, compared with modest gains of 0.6% and 14.7% over 3 and 5 years respectively. Recent...

Advanced Micro Devices (AMD) stock is back in focus after Samsung signed a new memorandum of understanding to supply HBM4 for AMD’s upcoming Instinct MI455X GPUs and DDR5 for future EPYC “Venice” CPUs. See our latest analysis for Advanced Micro Devices. Despite the Samsung MOU and a string of AI partnerships, AMD’s 1-month share price return of 3.79% and year-to-date share price return of 10.74% sit in contrast to its much stronger 1-year total shareholder return of 87.76%. This points to...

Recent commentary on First Busey highlights pressure on its net interest margin and a projected decline in tangible book value, raising questions about the bank’s underlying credit quality as of March 2026. The gap between the company’s revenue growth and weaker earnings per share growth points to less profitable incremental business, a concern for long-term returns on its banking and wealth operations. We’ll now examine how these concerns about credit quality and margin pressure shape First...

If you are wondering whether Axogen at around US$30.94 is still good value after a strong run, or if you are arriving late to the story, this breakdown will help put the current share price into context. The stock has pulled back, with a 4.2% decline over the last 7 days and a 6.9% decline over the last 30 days. This is despite a 1 year return of 72.8% and a very large gain over 3 years. Recent coverage has focused on how Axogen fits into the broader medical equipment space and what that...

Chevron (NYSE:CVX) is moving to expand operations and production capacity in Venezuela as the country opens more of its oil sector to foreign investment. The company is securing additional Venezuelan assets and working within new investment friendly laws that increase access for international producers. These steps come while the Strait of Hormuz remains closed, disrupting established crude shipping routes and trade flows. Chemical and energy majors like Chevron depend on access to...

Plug Power (NasdaqCM:PLUG) is preparing to supply up to 250 MW of hydrogen powered electricity into a potential PJM Interconnection grid auction. The company is in discussions with data center operators and utilities about long term hydrogen based power contracts. This development follows recent restructuring, asset sales, project cancellations and executive changes at Plug Power. For investors tracking NasdaqCM:PLUG, this marks a shift in focus toward grid scale power supply at a time when...

Why Freeport-McMoRan Stock Is Back in Focus Freeport-McMoRan (FCX) is drawing fresh attention after recent analyst estimate revisions and expectations for a significant year-over-year earnings per share increase, a shift in sentiment that appears closely tied to the stock’s latest move. See our latest analysis for Freeport-McMoRan. Recent trading has been choppy, with the share price at US$55.45 after a 1-day share price return decline of 4.54% and a 30-day share price return decline of...

In March 2026, AirSculpt Technologies announced preliminary fiscal 2025 revenue of US$151.8 million, guided first-quarter 2026 revenue to US$38.5–US$39.5 million with flat same-store sales at the midpoint, and disclosed a short delay in filing its annual report due to technical inter-company classification work. On the same day, major shareholder Jorey Chernett increased their stake by purchasing 105,848 shares, highlighting insider confidence even as same-store revenue for fourth-quarter...

Bank OZK acquired a new position in shares of Marvell Technology during Q3 2026. The move adds exposure to the semiconductor sector alongside Bank OZK’s core banking activities. Investors may view the position as a signal of evolving capital allocation priorities at NasdaqGS:OZK. NasdaqGS:OZK is entering this move with its shares at $43.74 and a mixed recent return profile, including a 37.0% gain over 3 years and a 29.5% gain over 5 years, alongside a 7.0% decline year to date. The new...

Why AAON (AAON) is on investors’ radar AAON (AAON) has drawn attention after recent share price weakness, with the stock down about 22% over the past month and 14% over the past week. This has prompted investors to reassess the HVAC specialist. See our latest analysis for AAON. Beyond the recent drop, AAON’s 90 day share price return of 5.25% contrasts with the 22.26% 30 day decline, while the 5 year total shareholder return of 74.13% points to a much stronger long term outcome. If this...

Pomerantz LLP’s investigation into Sempra (SRE) following its February 2025 earnings miss and reduced 2025 guidance has put the stock under closer scrutiny for potential securities law issues. See our latest analysis for Sempra. Against the backdrop of the earnings miss and legal scrutiny, Sempra’s share price has still produced a 90 day share price return of 8.93% and a 1 year total shareholder return of 39.03%. This suggests that recent momentum has been building from a stronger long term...

Zenas BioPharma (ZBIO) is back in focus after reporting a much wider Q4 net loss alongside a fresh going concern warning, while also securing access to a sizeable multi tranche debt facility extending into 2031. See our latest analysis for Zenas BioPharma. The wider Q4 loss, going concern warning and new debt facility have coincided with a 34.3% 3 month share price return decline and a weaker near term trend. However, the 1 year total shareholder return of about 2.8x still stands out. If you...